NL-OMON21573CompletedNot Applicable
The pharmacokinetics of nimodipine, intravenous and orally, in patients with subarachnoidal hemorrhage admitted in the intensive care.
none0 sites12 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 12
Study Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. All patients admitted on the ICU with subarachnoidal hemorrhage (SAB), treated according to our SAB-protocol;
- •2. Adults aged 18 - 70 years old.
Exclusion Criteria
- •1. Pregnancy;
- •2. Expected mortality < 24 hours;
Investigators
Similar Trials
Completed
Not Applicable
The pharmacokinetics of nimodipine, intravenous and orally, in patients with subarachnoidal haemorrhage admitted in intensive careSubarachnoidal haemorrhageCirculatory SystemCerebrovascular diseasesISRCTN45381163VU University Medical Centre (VUMC) (The Netherlands)12
Active, not recruiting
Phase 1
Application of nimodipine to the cranial nerves during vestibular schwannoma resection to avoid post-operative facial weakness and deafnessPatients with vestibularis schwanomma undergoing microsurgical resectionEUCTR2020-005215-46-ATDepartment of Neurosurgery, Medical University of Vienna30
Recruiting
Phase 3
Evaluation of therapeutic effect of nimodipine on facial nerve injury following brain tumor surgeryIRCT20120527009878N8Tabriz University of Medical Sciences50
Not yet recruiting
Not Applicable
To study how nivolumab behaves in Indian cancer patientsCTRI/2020/06/026176Advanced Cancer for Treatment Research and Education in cancer
Terminated
Phase 1
Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected PatientsHIV InfectionsNCT02184286Boehringer Ingelheim5